ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle

ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

ADMA stock rocketed Friday after the biotech company inked a deal with KPMG as its new independent registered public accounting firm.

Recommended Stories